Artificial Intelligence in Genomics Market (By Offering: Software, Services; By Application: Drug Discovery & Development, Precision Medicine, Diagnostics, Animal Research and Agriculture, Others; By End User: Pharmaceutical & Biotech Companies, Government Organizations, Research Organizations, Others; By Technology: Machine Learning, Other Technologies; By Functionality) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2022 - 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence in Genomics Market 

5.1. COVID-19 Landscape: Artificial Intelligence in Genomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence in Genomics Market, By Offering

8.1. Artificial Intelligence in Genomics Market, by Offering, 2022-2030

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Artificial Intelligence in Genomics Market, By Application

9.1. Artificial Intelligence in Genomics Market, by Application, 2022-2030

9.1.1. Drug Discovery & Development

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Precision Medicine

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Diagnostics

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Animal Research and Agriculture

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Artificial Intelligence in Genomics Market, By End User 

10.1. Artificial Intelligence in Genomics Market, by End User, 2022-2030

10.1.1. Pharmaceutical & Biotech Companies

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Government Organizations

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research Organizations

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Artificial Intelligence in Genomics Market, By Technology

11.1. Artificial Intelligence in Genomics Market, by Technology, 2022-2030

11.1.1. Machine Learning

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Other Technologies

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Artificial Intelligence in Genomics Market, By Functionality

12.1. Artificial Intelligence in Genomics Market, by Functionality, 2022-2030

12.1.1. Genome Sequencing

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Gene Editing

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Clinical Workflows

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Predictive Genetic Testing & Preventive Medicine

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Artificial Intelligence in Genomics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Offering (2017-2030)

13.1.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.3. Market Revenue and Forecast, by End User (2017-2030)

13.1.4. Market Revenue and Forecast, by Technology (2017-2030)

13.1.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Offering (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.3. Market Revenue and Forecast, by End User (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7. Market Revenue and Forecast, by Functionality (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Offering (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.3. Market Revenue and Forecast, by End User (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Technology (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Offering (2017-2030)

13.2.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.3. Market Revenue and Forecast, by End User (2017-2030)

13.2.4. Market Revenue and Forecast, by Technology (2017-2030) 

13.2.5. Market Revenue and Forecast, by Functionality (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Offering (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.6.3. Market Revenue and Forecast, by End User (2017-2030)

13.2.7. Market Revenue and Forecast, by Technology (2017-2030) 

13.2.8. Market Revenue and Forecast, by Functionality (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Offering (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.9.3. Market Revenue and Forecast, by End User (2017-2030)

13.2.10. Market Revenue and Forecast, by Technology (2017-2030)

13.2.11. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Offering (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.3. Market Revenue and Forecast, by End User (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Technology (2017-2030)

13.2.13. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Offering (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.3. Market Revenue and Forecast, by End User (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Technology (2017-2030)

13.2.15. Market Revenue and Forecast, by Functionality (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Offering (2017-2030)

13.3.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.3. Market Revenue and Forecast, by End User (2017-2030)

13.3.4. Market Revenue and Forecast, by Technology (2017-2030)

13.3.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Offering (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.3. Market Revenue and Forecast, by End User (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Technology (2017-2030)

13.3.7. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Offering (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.3. Market Revenue and Forecast, by End User (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Technology (2017-2030)

13.3.9. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Offering (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.3. Market Revenue and Forecast, by End User (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Offering (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.3. Market Revenue and Forecast, by End User (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Offering (2017-2030)

13.4.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.3. Market Revenue and Forecast, by End User (2017-2030)

13.4.4. Market Revenue and Forecast, by Technology (2017-2030)

13.4.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Offering (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.3. Market Revenue and Forecast, by End User (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Technology (2017-2030)

13.4.7. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Offering (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.3. Market Revenue and Forecast, by End User (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Technology (2017-2030)

13.4.9. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Offering (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.3. Market Revenue and Forecast, by End User (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Offering (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.3. Market Revenue and Forecast, by End User (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Offering (2017-2030)

13.5.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.3. Market Revenue and Forecast, by End User (2017-2030)

13.5.4. Market Revenue and Forecast, by Technology (2017-2030)

13.5.5. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Offering (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.3. Market Revenue and Forecast, by End User (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Technology (2017-2030)

13.5.7. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Offering (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.3. Market Revenue and Forecast, by End User (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Functionality (2017-2030)

Chapter 14. Company Profiles

14.1. IBM

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. NVIDIA Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Benevolent AI

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Verge Genomics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. MolecularMatch, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. SOPHiA GENETICS

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. PrecisionLife Ltd.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Lifebit

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. FDNA, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Empiric Logic

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY

   USD 4900.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample